In our model, a2NTD treatment stimulates neutrophils to secrete enhanced amount of TNFα, IL-1 and IL-6 suggesting that neutrophils in the site of the tumor may be a potential source of these mediators. The gene discussed is TNF; the disease is neoplasm.